secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001193125-24-055935
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics raises $350M in oversubscribed private placement of 8.33M shares at $42/sh
--------------------------------------------------------------------------------

- Private placement of 8,333,334 common shares at $42.00/share raises ~$350M gross proceeds.
- Oversubscribed placement includes new and existing investors like Adage Capital, Driehaus, EcoR1, Janus Henderson.
- Net proceeds to fund R&D of clinical-stage candidates, working capital, and general corporate purposes.
- Closing expected March 1, 2024; resale registration statement to be filed within 40 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000119312524055935/0001193125-24-055935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000119312524055935/d773342d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-055935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer